The effects and costs of cranberry use to prevent symptomatic urinary tract infections in nursing home residents.

The effects and costs of cranberry use to prevent symptomatic urinary tract infections in nursing home residents. - CRANBERRY

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31677

Enrollment

1000

Registered

2008-08-07

Start date

2008-01-04

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation of the bladder

Interventions

Two times a day one capsule of cranberry during one year.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >= 65 years Life expectancy > 1 month

Exclusion criteria

Exclusion criteria: coumarine users acute illness

Design outcomes

Primary

Measure	Time frame
•Effects study: time to first symptomatic UTI, number of symptomatic UTIs per included resident, quality of life, care dependency, compliance, side effects, medical consumption, resistance patterns of etiologic microbial agents, and costs. •The economic evaluation will include a cost-effectiveness analysis (costs per prevented UTI) and a cost-utility analysis (costs per QALY).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)